FindTrial
Sign In

Study on the value of continous renal replacement therapy to improve the prognosis of patients with AKI caused by urosepsis

Study on continuous renal replacement therapy on AKI caused by urosepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039249
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-19
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urosepsis

Interventions

experimental group:Renal Replacement Therapy
control group:ordinary therapy

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years of age who signed informed consent; 2. The subjects or family members are well aware of the purpose of the study and are willing and able to comply with the requirements to complete the study; 3. The selected case criteria meet the 2016 diagnostic criteria for sepsis.

Exclusion criteria

Exclusion criteria: 1. Patients lack of independent capacity; 2. Sepsis do not infect by urinary tract infections; 3. Have history of malignant tumor or other acute and chronic diseases. 4. Have history of immunodeficiency, or use of immunosuppressive drugs. 5. Other reasons for patients do not want include the study patients had previous renal impairmen.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
White Blood Cell;circRNA730;CRP;PCT;TNF-a;IL-1;IL-6;IL-8;—

Countries

China

Contacts

Public ContactZhou Juan

Shanghai Tongji Hospital

zhoujuan-4137904@163.com+86 13540188841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026